Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-05
2000-05-09
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514814, A61K 3170, C07H 19167
Patent
active
06060459&
ABSTRACT:
The invention relates to certain oxypurine nucleosides, congeners of such oxypurine nucleosides, and acyl derivatives thereof, and compositions which contain at least one of these compounds. The invention also relates to methods of treating or preventing hematopoietic disorders and modifying hematopoiesis, and treating or preventing inflammatory diseases and bacterial infections by administering a compound or composition of the present invention to an animal.
REFERENCES:
patent: 4022963 (1977-05-01), Deutsch
patent: 4539205 (1985-09-01), Goodman et al.
patent: 4643992 (1987-02-01), Goodman et al.
patent: 4849411 (1989-07-01), Goodman et al.
patent: 5093318 (1992-03-01), Goodman et al.
patent: 5116615 (1992-05-01), Gokcen et al.
patent: 5136030 (1992-08-01), Chen
patent: 5206219 (1993-04-01), Desai
patent: 5320846 (1994-06-01), Bistrian et al.
patent: 5441942 (1995-08-01), Goodman et al.
patent: 5539098 (1996-07-01), Krenitsky et al.
Chemical Abstracts, vol. 78, Abstract No. 92644, 1970, Markley et al, J. Trauma, 10: 598-607, 1970.
Martin et al, Journal of Pharmaceutical Sciences, vol. 76, No. 2, issued Feb. 1987, "Synthesis and Antiviral Activity of Various Esters of 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine;" p. 180-184.
Wright, G., Blood, vol. 69, No. 1, issued Jan. 1987, "A Role For Guanine Ribonucleotides in the Regulation of Myeloid Cell Maturation," p. 334-337.
Oshita et al, Blood, vol. 49, No. 4, Issued Apr. 1977, "cGMP Stimulation of Stem Cell Proliferation," p. 585-591.
Fleming, W.A., et al, J. Cell. Physiol., vol. 88, issued 1976, "Cellular Responsiveness to Stimulation in Vitro: Increased Responsiveness to Colony Stimulating Factor of Bone Marrow Colony-forming Cells Treated with Surface-Active Agents and Cyclic 3', 5' AMP," p. 323-330.
Sugahara et al, Brookhaven Symposium in Biology, issued 1968, "Studies on the Effect of Chemical Treatment on the Survival of Repeatedly Irradiated Mice," p. 284-302.
Bennett, D.W., and Drury, A.N., J. Physiol. 72:288 (1931), p. 303-306.
Beljanski et al, Cancer Treat., Rep. 67:611-619 (1983).
Sigma Chemical Company 1991 Catalog: 1702-1704.
Morikawa, K., et al, Cancer Research 47:37-41 (1987).
Huang, G., et al, Zhonghua Zueyexue Zazhi 11(2):66-68 (Abstract).
Bamat Michael K.
Butler James C.
Hiltbrand Bradley M.
Shirali Shyam
von Borstel Reid W.
Kunz Gary L.
Pro-Neuron, Inc.
LandOfFree
Enhancing blood cell count with oxypurine nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancing blood cell count with oxypurine nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing blood cell count with oxypurine nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065196